Indomethacin Plus Biological Therapy in Treating Patients With Advanced Melanoma

NCT00002535 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Melanoma (Skin)

Interventions

BIOLOGICAL: aldesleukin
BIOLOGICAL: lymphokine-activated killer cells
BIOLOGICAL: therapeutic tumor infiltrating lymphocytes
DRUG: cyclophosphamide
DRUG: indomethacin

Sponsor

St. Luke's Medical Center